Seer, Inc.

NASDAQ:SEER

2.31 (USD) • At close December 20, 2024
Bedrijfsnaam Seer, Inc.
Symbool SEER
Munteenheid USD
Prijs 2.31
Beurswaarde 136,212,747
Dividendpercentage 0%
52-weken bereik 1.51 - 2.625
Industrie Biotechnology
Sector Healthcare
CEO Dr. Omid C. Farokhzad M.D., Ph.D.
Website https://seer.bio

An error occurred while fetching data.

Over Seer, Inc.

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials.

Vergelijkbare Aandelen

Ocugen, Inc. logo

Ocugen, Inc.

OCGN

0.774 USD

Janux Therapeutics, Inc. logo

Janux Therapeutics, Inc.

JANX

56.83 USD

OptimizeRx Corporation logo

OptimizeRx Corporation

OPRX

4.91 USD

AirSculpt Technologies, Inc. logo

AirSculpt Technologies, Inc.

AIRS

5.35 USD

PetMed Express, Inc. logo

PetMed Express, Inc.

PETS

4.97 USD

MaxCyte, Inc. logo

MaxCyte, Inc.

MXCT

4.24 USD

Nurix Therapeutics, Inc. logo

Nurix Therapeutics, Inc.

NRIX

19.83 USD

Affimed N.V. logo

Affimed N.V.

AFMD

1.19 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)